Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors [clinicaltrials:NCT00010023]
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors [clinicaltrials:NCT00010023]
Bio2RDF identifier
NCT00010023
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00010023
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... or metastatic solid tumors .
brief title [clinicaltrials_vocabulary:brief-title]
Capecitabine Combined With Cis ...... ced or Metastatic Solid Tumors
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
- ...... study within 1-3
years.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-02-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
advanced adult primary liver cancer
carcinoma of the appendix
extensive stage small cell lung cancer
gastrointestinal stromal tumor
localized unresectable adult primary liver cancer
metastatic gastrointestinal carcinoid tumor
newly diagnosed carcinoma of unknown primary
pulmonary carcinoid tumor
recurrent adenoid cystic carcinoma of the oral cavity
recurrent adult primary liver cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-04-04T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00010023
official title [clinicaltrials_vocabulary:official-title]
A Phase I Study of Oral Fluoro ...... Cancer of the Digestive System
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000068434
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2007-08-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
P30CA016087
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2000-08-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2011-04-01T00:00:00Z
identifier
clinicaltrials:NCT00010023
title
Capecitabine Combined With Cis ...... ced or Metastatic Solid Tumors
@en
type
label
Capecitabine Combined With Cis ...... s [clinicaltrials:NCT00010023]
@en